U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07240753) titled 'A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma' on Nov. 15.
Brief Summary: Cervical large cell neuroendocrine carcinoma (LCNEC) exhibits highly aggressive biological behavior, including strong invasiveness, a high propensity for metastasis, drug resistance, and poor prognosis, necessitating heightened clinical and pathological awareness. This study aims to summarize the clinical characteristics of LCNEC and analyze various prognostic factors to enhance understanding and vigilance toward this disease. Combined with precise pathological diagnosis, improving diagnostic accuracy is crucial for formulating treatment str...